Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 22 February, 2024|Author: Getaka | Social: X Twitter Profile
Stock Ticker - BSE: 531335 | NSE: ZYDUSWELL

Fundamental Analysis of Zydus Wellness Ltd

About the Company - Zydus Wellness Ltd

Zydus Wellness Ltd. is a Public Limited Listed company incorporated on 01/11/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L15201GJ1994PLC023490 and registration number is 023490. Currently company belongs to the Industry of Personal Care. Company’s Total Operating Revenue is Rs. 216.25 Cr. and Equity Capital is Rs. 63.63 Cr. for the Year ended 31/03/2022.
Personal CareZydus Corporate Park, Scheme No. 63, Survey No. 536 Ahmedabad Gujarat
NamePosition Held
Dr. Sharvil P PatelChairman
Mr. Tarun G AroraWholeTime Director & CEO
Mr. Kulin S LalbhaiIndependent Director
Mr. Savyasachi S SenguptaIndependent Director
Ms. Dharmishtaben N RavalIndependent Director
Mr. Srivishnu Raju NandyalaIndependent Director
Mr. Ashish P BhargavaNominee Director
Mr. Ganesh N NayakNon Executive Director
Mr. Akhil A MonappaIndependent Director

Zydus Wellness Ltd. Share Price Update

Share PriceValue
Previous Day₹1,580.40

Basic Stock Data of Zydus Wellness Ltd

Market Cap 10,114 Cr.
Current Price 1,589
High / Low1,721/1,390
Stock P/E35.7
Book Value 818
Dividend Yield0.32 %
ROCE5.93 %
ROE6.40 %
Face Value 10.0

Data Source:

Competitors of Zydus Wellness Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Gillette India Ltd 21,493 Cr. 6,5957,336/4,13555.0 3161.27 %52.0 %38.5 % 10.0
Marico Ltd 69,797 Cr. 539595/46347.6 32.60.84 %41.9 %35.8 % 1.00
Hindustan Unilever Ltd (HUL) 5,58,087 Cr. 2,3752,770/2,34754.1 2141.64 %26.6 %20.5 % 1.00
Procter & Gamble Hygiene and Health Care Ltd 53,828 Cr. 16,58219,250/13,10171.2 3240.63 %101 %80.6 % 10.0
Industry Average37 Cr140.7556.98221.651.1%55.38%43.85%5.5

Zydus Wellness Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Operating Profit27.1249.53145.36140.4230.5432.29141.50148.1016.2028.19144.60116.5016.80
OPM %7.93%12.98%24.00%23.50%7.96%8.32%22.12%21.27%3.78%6.78%20.28%16.59%3.82%
Other Income-95.14-31.661.792.393.362.691.96-0.901.400.84-6.50-11.804.10
Profit before tax-105.341.74132.66130.8021.1022.72131.40137.008.2019.31126.3093.408.60
Tax %0.00%0.00%-0.35%0.00%-1.75%-2.55%-1.45%0.00%-3.66%-1.29%-15.04%-18.20%31.40%
Net Profit-105.341.74133.13130.8021.4723.30133.30137.008.5019.56145.30110.405.90
EPS in Rs-16.550.2720.9220.563.373.6620.9521.531.343.0722.8317.350.93

Zydus Wellness Ltd Quarterly Chart

Zydus Wellness Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit7797851009199125185321344345337306
OPM %23%25%21%23%23%23%24%22%18%18%17%15%13%
Other Income916192832323528-33-12310-5-13
Profit before tax82108104120117124150171121112306291248
Tax %17%8%5%7%10%10%9%-0%-17%-6%-1%-7%
Net Profit699998111105111137171142119309310281
EPS in Rs17.3224.8524.6927.8826.4327.8934.2729.3324.5818.6648.5448.7844.18
Dividend Payout %29%24%24%22%25%23%23%17%20%27%10%10%

Zydus Wellness Ltd Profit & Loss Yearly Chart

YoY Net Profit Growth
YoY Net Profit Growth (%)43.48%-1.01%13.27%-5.41%5.71%23.42%24.82%-16.96%-16.20%159.66%0.32%
Change in YoY Net Profit Growth (%)0.00%-44.49%14.28%-18.67%11.12%17.71%1.39%-41.78%0.76%175.86%-159.34%

Zydus Wellness Ltd Growth

Compounded Sales Growth
10 Years:19%
5 Years:34%
3 Years:8%
Compounded Profit Growth
10 Years:13%
5 Years:19%
3 Years:21%
Stock Price CAGR
10 Years:13%
5 Years:5%
3 Years:-5%
1 Year:10%
Return on Equity
10 Years:8%
5 Years:6%
3 Years:6%
Last Year:6%

Zydus Wellness Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital39393939393939585864646464
Other Liabilities80939910289100112503610548461413272
Total Liabilities2673494255085686828295,4595,5905,6665,6925,8335,831
Fixed Assets96949584821031044,5674,6744,6674,7104,7324,734
Other Assets1712553244233915505778358029959431,0181,018
Total Assets2673494255085686828295,4595,5905,6665,6925,8335,831

Zydus Wellness Ltd Reserves and Borrowings Chart

Zydus Wellness Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 6269916990776914925928723792
Cash from Investing Activity -2131329-28-72-59-4,092-17-10-59-85
Cash from Financing Activity -18-23-27-27-58-6-24,052-260-216-234-138
Net Cash Flow425977714-18109-1860-56-132

Zydus Wellness Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days11213364224182634
Inventory Days1041201087673127113393168158135146
Days Payable159136191146191264254662289189136100
Cash Conversion Cycle-54-14-82-69-116-134-135-227-97-132580
Working Capital Days-42-32-48-37-38-36-84-3123165
ROCE %50%48%35%32%26%23%22%7%6%6%6%6%

Zydus Wellness Ltd Financial Efficiency Indicators Chart

Zydus Wellness Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders48,17858,03555,51359,82367,20866,84570,70968,96970,79073,02976,59075,369

Zydus Wellness Ltd Shareholding Pattern Chart

No. of Zydus Wellness Ltd Shareholders

Zydus Wellness Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Nippon India Small Cap Fund22211060.84344.6
ICICI Prudential Value Discovery Fund8434820.37130.87
SBI Small Cap Fund5671820.3888
ICICI Prudential Multicap Fund2436270.437.8
Tata India Consumer Fund2290002.0235.53
Aditya Birla Sun Life India GenNext Fund1567800.5624.32
Tata Flexi Cap Fund1400000.8721.72
ICICI Prudential Bharat Consumption Fund1171650.8918.18
ICICI Prudential FMCG Fund - Dividend887830.9413.77
ICICI Prudential FMCG Fund - Growth887830.9413.77

Zydus Wellness Ltd ROCE Trend

Zydus Wellness Ltd EPS Trend

Zydus Wellness Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)48.7848.5419.5524.5840.10
Diluted EPS (Rs.)48.7848.5419.5524.5840.10
Cash EPS (Rs.)52.7152.2522.6129.1631.87
Book Value[Excl.RevalReserv]/Share (Rs.)805.07761.28717.87600.18587.28
Book Value[Incl.RevalReserv]/Share (Rs.)805.07761.28717.87600.18587.28
Revenue From Operations / Share (Rs.)354.36315.75293.36306.42146.17
PBDIT / Share (Rs.)53.7555.8155.5257.5438.79
PBIT / Share (Rs.)49.8252.1051.5752.9636.62
PBT / Share (Rs.)45.7148.0917.6321.0329.59
Net Profit / Share (Rs.)48.7848.5418.6624.5829.70
NP After MI And SOA / Share (Rs.)48.7848.5418.6624.5829.33
PBDIT Margin (%)15.1617.6718.9218.7726.53
PBIT Margin (%)14.0516.5017.5717.2825.05
PBT Margin (%)12.8915.236.016.8620.24
Net Profit Margin (%)13.7615.376.368.0220.31
NP After MI And SOA Margin (%)13.7615.376.368.0220.06
Return on Networth / Equity (%)6.056.372.594.094.99
Return on Capital Employeed (%)6.166.736.706.134.29
Return On Assets (%)5.325.422.092.533.09
Long Term Debt / Equity (X)
Total Debt / Equity (X)
Asset Turnover Ratio (%)
Current Ratio (X)1.311.
Quick Ratio (X)0.650.580.620.780.85
Inventory Turnover Ratio (X)0.890.780.540.804.64
Dividend Payout Ratio (NP) (%)10.2510.300.0040.6918.48
Dividend Payout Ratio (CP) (%)9.489.570.0034.3017.20
Earning Retention Ratio (%)89.7589.700.0059.3181.52
Cash Earning Retention Ratio (%)90.5290.430.0065.7082.80
Interest Coverage Ratio (X)21.2713.924.222.377.43
Interest Coverage Ratio (Post Tax) (X)20.9313.113.992.337.04
Enterprise Value (Cr.)10116.339760.9712849.968915.138891.82
EV / Net Operating Revenue (X)4.494.866.885.0510.55
EV / EBITDA (X)29.5827.4836.3726.8739.75
MarketCap / Net Operating Revenue (X)4.374.756.724.238.88
Retention Ratios (%)89.7489.690.0059.3081.51
Price / BV (X)1.931.972.752.162.21
Price / Net Operating Revenue (X)4.374.756.724.238.88

Zydus Wellness Ltd Profitability Ratios (%)

Zydus Wellness Ltd Liquidity Ratios

Zydus Wellness Ltd Liquidity Ratios (%)

Zydus Wellness Ltd Interest Coverage Ratios (X)

Zydus Wellness Ltd Valuation Ratios

Fair Value / Intrinsic Value of Zydus Wellness Ltd

Fair Value: ₹1874.95

The stock is undervalued by 18.00% compared to the current price ₹1589

*Investments are subject to market risks

Strength and Weakness of Zydus Wellness Ltd

  1. The stock has a high average ROCE of 22.25%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -11.00, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -69.67, which is a positive sign.
  4. The company has higher reserves (2,218.85 cr) compared to borrowings (363.38 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (288.62 cr) and profit (156.77 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 48.61 and average Dividend Yield of 18.09%.

Should I Buy Zydus Wellness Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in Zydus Wellness Ltd:
    1. Net Profit Margin: 13.76%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 6.16% (Industry Average ROCE: 56.5%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 20.93
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 0.65
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E of 35.7 (Industry average Stock P/E: 57)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.05
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Zydus Wellness Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE